Both SREBP-1 and SREBP-2 contribute to the regulation of lipid biosynthesis [62] and SREBP-1 signaling due to B7-H3 overexpression has been correlated with increased glycerolipid production and aggressive NSCLC [63]. The gene discussed is CD276; the disease is non-small cell lung carcinoma.